Craneware PLC, a leading provider of Value Cycle solutions for the US healthcare market, has announced the extension of its share buyback program for an additional three months, until 17 July 2024. The program, initially set to expire on 17 April 2024, will continue under the same terms as previously announced. This decision reflects the company's confidence in its financial position and its commitment to delivering value to its shareholders.
Craneware PLC, listed on AIM (CRW.L), is known for its automated value cycle solutions, including 340B management, which help US healthcare providers plan, execute, and monitor operational and financial performance. The company's Trisus data and applications platform is a key tool for healthcare providers navigating the journey to financially sustainable value-based care, combining revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform.
The company's CEO, Keith Neilson, and CFO, Craig Preston, are available for further information. The company's strategic communications are handled by Alma Strategic Communications, and the contact details for investor relations are provided for Peel Hunt, Investec Bank PLC, and Berenberg.
Craneware PLC's decision to extend the share buyback program underscores its confidence in its financial position and its commitment to delivering value to its shareholders. This move aligns with the company's position as a market leader in providing automated value cycle solutions for the US healthcare market, showcasing its dedication to supporting healthcare providers in delivering quality care to their communities.